SynthesisBiological trace element research2026
Zinc-Induced Hematologic Toxicities: A Systematic Review of Descriptive Studies.
Synthesis in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Zinc is an essential trace element, but excessive exposure can disrupt copper metabolism and lead to clinically significant hematologic abnormalities. This systematic review aimed to synthesize published evidence on zinc-induced hematologic toxicities. Literature search was performed in PubMed and Scopus to identify descriptive studies reporting zinc-induced hematologic toxicity in humans. Eligible studies described anemia, neutropenia, leukopenia, thrombocytopenia, pancytopenia, or bone marrow suppression attributed to zinc exposure. Data on patient demographics, zinc source and dose, duration of exposure, laboratory and bone marrow findings, treatment strategies, and outcomes were extracted. Study quality was assessed using Joanna Briggs Institute critical appraisal tools. Thirty-four publications describing 37 individual cases were included, spanning from 1972 to 2025. Zinc exposure most commonly resulted from oral supplements, denture adhesive creams, and coin ingestion, with reported daily elemental zinc doses ranging from approximately 50 mg to more than 1500 mg and exposure durations ranging from weeks to years. Anemia was present in nearly all cases, most often accompanied by neutropenia and leukopenia, with pancytopenia occurring in cases of severe or prolonged exposure. Serum copper levels were reduced in all patients. Bone marrow examination frequently revealed vacuolated hematopoietic precursors and ring sideroblasts, leading to frequent initial misdiagnosis as myelodysplastic syndrome. Discontinuation of zinc exposure with copper supplementation resulted in hematologic recovery in the majority of cases, typically within weeks to months, while neurological manifestations improved more slowly and were sometimes incomplete. Zinc-induced hematologic toxicity is an uncommon but underrecognized and largely reversible condition. Excessive zinc exposure should be considered in patients presenting with unexplained anemia and cytopenias. Routine assessment of zinc exposure and copper status can prevent misdiagnosis, support timely treatment, and decrease the risk of persistent neurological complications.
Indexed as
Identifiers
42087025What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.